Contact sensitivity (CS) is a cutaneous T h 1 response that is induced by skin painting with reactive hapten. In prior in vivo studies of CS, we showed that recombinant soluble αβTCR (sTCR) acted non-specifically to protect CS-effector T cells from suppression, but no molecular mechanism was determined. In the current study, we employed an in vitro system to investigate the mechanism of how sTCR protect CS-effector T cells from suppression. Immune CS-effector cells and appropriate hapten-conjugated antigen-presenting cells (APC) were incubated together with down-regulatory culture supernatant produced by suppressive spleen cells from mice tolerized i.v. with specific hapten, which produced strong inhibition of IFN-γ production by the CS-effector cells. Importantly, addition of two different sTCR, of unrelated specificity, reversed this down-regulation and thus restored IFN-γ production. We found that the APC, and not the CS-effector T cells, were the locus of the sTCR-mediated protection and showed direct binding of sTCR to APC by flow cytometry. Further, addition of anti-IL-12 showed that sTCR protection was due to IL-12 induced by sTCR and released by the APC, and was confirmed by ELISA measurement of IL-12 induced in APC supernatants by sTCR incubation. These results indicated a possible new regulatory loop in which suppression was reversed by IL-12 derived from APC, following direct surface binding of sTCR, and enhanced by IFN-γ production from the T h 1 CS-effector cells.
Introduction

Cutaneous contact hypersensitivity (CS) is a T cell-mediated
TCR of an appropriate subset of the peripheral recirculating T cell repertoire, that continually passes through the draining immune reaction in the epidermis in response to topically applied reactive hapten. Such haptens covalently couple to lymph nodes (4, 5) . Following this sensitization, subsequent CS responses are elicited by topical painting challenge with cell surface molecules; probably most importantly to self peptides in the groove of MHC class II molecules of antigenthe hapten antigen, on a different skin site in the ear. This probably again results in hapten conjugation of self peptides presenting cells (APC); mainly epidermal Langerhans cells (1) (2) (3) . During the afferent or sensitization phase of CS, these in MHC class II molecules on local APC, leading this time to elicitation of the delayed time course CS responses; due to local Langerhans APC migrate, carrying the hapten from the sensitization area in the epidermis to the draining lymph local infiltration of a few circulating antigen-specific immunized T cells, derived from the previously sensitized T cell repertoire nodes, and subsequently present the hapten-self peptide-MHC class II complexes to particular antigen-MHC-specific and to their subsequent local activation (2, 6 ). These few antigen-activated, antigen-specific, CS-effector T cells then stimulation of APC to release IL-12 that strengthened CSeffector T h 1 T cells for production of IFN-γ. produce certain T h 1 cytokines, such as IFN-γ, which is the crucial cytokine in CS reactions, to recruit and then activate large numbers of non-specific bone marrow-derived leukoMethods cytes, to constitute the inflammatory response of CS (7, 8) .
We recently demonstrated that an antigen-specific upMice regulatory factor that was produced by an established T cell Male CBA/J mice, 6-8 weeks old, were obtained from Jackson hybridoma contained determinants of αβ TCR and had a Laboratories (Bar Harbor, ME), and were kept in filter topped protective effect in vivo on CS T cell responses, specifically microisolators and rested for at least 1 week before use. by preventing down-regulation due to suppressive cells or factor (9) (10) (11) . More recently we employed an analogous upReagents regulatory recombinant soluble αβTCR (sTCR) in an in vivo Picryl chloride [trinitrophenyl (TNP)] chloride (PCl) (Chemica adoptive cell transfer system and found that pretreatment of Alta, Edmonton, Alberta, Canada), recrystallized from ethanol/ CS-effector cells with recombinant sTCR prior to adoptive cell H 2 O and then stored in a light-protected desiccator at room transfer also protected the cells from the suppressive factor temperature, trinitro-benzene sulfonic acid (TNBSA) (Wako TsF (12, 13) . However, and importantly, in this system the Pure Chemicals, Osaka, Japan), methotrexate, (Calbiochem, recombinant sTCR did not act antigen specifically to protect La Jolla, CA), PI-PLC, mitomycin C, biotinylated-BSA, (Sigma, CS-effector cells (12, 13) , suggesting that both antigenSt Louis, MO), and Protein A-Sepharose and CNBr-activatedspecific and antigen-non-specific potential effects of sTCR Sepharose 4B (Pharmacia, Piscataway, NJ) were obtained could be involved in regulating the function of CS-effector from the manufacturers. RPMI, MEM, FBS, DMEM (Gibco/BRL, T cells.
Grand Island NY), biotin-NHS, BCA protein assay reagent and Although it is generally recognized that tolerized cells from horse IgG protein standard (Pierce, Rockford, IL) also were recipients treated i.v. with high doses of antigen and their obtained from the manufacturer. soluble suppressive factors can down-regulate immune responses, the nature of these regulatory T cells and their
Cytokines and antibodies factors have not been characterized fully (14, 15) . Several
Murine recombinant IL-12 and sheep polyclonal antibody to other laboratories, working in CS systems, have shown that murine IL-12 were gifts of Dr Stanley F. Wolf (Genetics Institute, αβ TCR genes encode portions of other analogous downCambridge, MA). FITC-conjugated Mac-3 mAb, rat antiregulatory soluble mechanisms and these analogs of sTCR mouse IFN-γ (IgG1, clone 18181D) and biotinylated-rat can in part suppress CS responses (16) (17) (18) (19) (20) (21) . However, the anti-mouse IFN-γ (IgG1, clone XMG1.2) were obtained from mechanisms of how up-regulatory and protective sTCR restore PharMingen (San Diego, CA). Rat anti-mouse IL-12 mAb suppressed CS responses are not understood.
(clones C15.6 and C17.8) were obtained from Genzyme In the current study, we investigated the non-antigen-(Cambridge, MA). Using procedures recommended by the specific up-regulatory effect of recombinant αβ sTCR on CSmanufacturer, we conjugated anti-mouse IL-12 mAb (C17.8) effector T cells, by employing an in vitro culture system. We with biotin to employ in an IL-12-specific sandwich ELISA. used recombinant sTCR that were derived from either D10 T Anti-TCR C β chain mAb was purified from supernatant of cells (a CD4 ϩ , T h 2, MHC class II-restricted clone) or from 2C cultured hybridoma (H57-597), that was a kind gift from Dr T cells (a CD8 ϩ , cytotoxic T lymphocyte, MHC class I-R. T. Kubo (22) (Cytel, La Jolla, CA). restricted clone). We purified sTCR from BW5147 thymoma Cell lines cells that were transfected with αβ TCR cDNA derived from these two T cell clones. Thus, to obtain a soluble form of BW5147 thymoma cells that were co-transfected with α and recombinant sTCR, the BW5147 thymoma cells were co-β chain cDNAs from D10 (CD4 ϩ , a class II-restricted T h 2 cell transfected with α and β chain cDNA of D10 or 2C TCR, clone) and 2C (CD8 ϩ , a class I-restricted cytotoxic T cell spliced to murine Thy-1 cDNA, encoding phosphatiylinositol clone) were used. BW5147 thymoma cells transfected with (PI) membrane anchor sequences, to provide each αβ TCR D10 and 2C TCR α and β chain cDNAs were engineered to heterodimer with a PI cell surface link (19) . Then, we obtained contain a PI linkage derived from Thy-1 cDNA, and were sTCR molecules by enzymatically cleaving the PI-linked TCR provided by Dr Alfred Bothwell, Yale University School of from the cell surface, following treatment with PI-specific Medicine (23). Cell lines were routinely negative on testing phospholipase C (PI-PLC) and purified the released sTCR on for mycoplasma. an anti-TCRβ mAb affinity column (11) (12) (13) . This procedure Preparation of recombinant sTCR allowed us to obtain a sufficient amount of relatively pure (Ͼ95%) sTCR to examine the immunoregulatory activity of D10 and 2C TCR transfected BW5147 cells were grown TCR in vitro. We determined whether recombinant sTCR in DMEM supplemented with 10% dialyzed FBS, penicillin/ could protect CS-effector cells from suppression in vitro, by streptomycin and 110 µM methotrexate for maximum dihydromeasuring antigen-specific IFN-γ production by CS-effector folate reductase gene-mediated amplification of αβ TCR cells that were stimulated in vitro with specific hapten-conjugheterodimer production and for maximal surface expression ated APC. Here we report that recombinant sTCR bound of TCR. Cells were harvested when their density reached 10 6 / directly to APC and overcame suppression in vitro. The ml. About 3ϫ10 9 cells were pooled, washed once with 50 ml of plain MEME, and then the pellet was resuspended in 9 ml mechanism of up-regulation by sTCR involved binding and 
in PBS
Biotinylation of sTCR at 37°C for 10 min and resulting TNP hapten-conjugated sTCR that were purified on an anti-αβ TCR mAb affinity column spleen cells were washed with PBS.
were dialyzed overnight against 0.1 M sodium bicarbonate Contact sensitization of mice buffer, pH 8.5, at 4°C and then mixed thoroughly with NHSbiotin reagent (Pierce, Rockford, IL). After incubation for 2 h Mice were contact sensitized by topical application of 100 µl on ice, the biotinylated sTCR were dialyzed overnight against of 5% PCl in an ethanol:acetone mixture (3:1) to the shaved PBS at 4°C. abdomen and four footpads (2, 6) .
Isolation of peritoneal exudate macrophages Cell culture for IFN-γ production by CS-effector cells
Peritoneal exudate macrophages were induced by i.p. injec-A single-cell suspension of lymph node cells (LNC), obtained tion of 2 ml thioglycolate culture medium (Difco, Detroit, MI). from 4 day contact sensitized mice, was prepared under Four days later peritoneal exudate cells (PEC) were harvested aseptic conditions. For stimulation with hapten-conjugated with 4 ml of ice-cold PBS containing 10 U/ml of heparin. PEC TNP-APC, 4ϫ10 5 immune LNC from PCl-sensitized mice were were washed 3 times with ice-cold PBS and resuspended at co-cultured with 4ϫ10 5 TNP-APC, unless otherwise stated, in 10 7 cells/ml in complete RPMI 1640 medium, and then these flat-bottomed 96-well tissue culture plates (Falcon, Franklin cells were surface adhered by incubation for 1 h at 37°C in Lakes, NJ), in 0.2 ml RPMI 1640 containing penicillin/strepto-100 mm glass Petri dishes in a 5% CO 2 humidified incubator. mycin, 2 mM L-glutamine, 25 mM HEPES, 5ϫ10 -5 M 2-Non-adherent cells were removed by aspiration and adherent mercaptoethanol and 10% FBS. Culture supernatants were cells were harvested by adding 0.05% trypsin. The enriched harvested to assess IFN-γ production 48 h later and stored adherent macrophage population was assessed by flow at -20°C until assayed.
cytometry for Mac-3 expression. Purity was always Ͼ95% and viability was Ͼ98%.
TNP-specific T cell suppressive factor (TsF)
Flow cytometric analysis of cell surface binding of sTCR TsF was prepared as described previously (9) (10) (11) (12) (13) . Briefly, mice were tolerized by i.v. injection twice, on days 0 and 3, Harvested macrophage-rich PEC were pelleted and resuspended in 0.1 ml of biotin-conjugated recombinant sTCR (10 with 0.35 ml of 1% TNBSA in PBS neutralized to pH 7.2 with 1 N NaOH. On day 7, mice were boosted by skin painting µg/10 6 cells) in PBS containing 2% FBS (PBS/FBS). After 30 min incubation on ice, cells were washed twice with ice-cold with 5% PCl in acetone:ethanol (1:3). The next day, spleen cell suspensions were harvested, and these tolerized spleen PBS/FBS. As a control, cells were preincubated with unlabeled sTCR or with biotinylated BSA, to determine background cells were cultured in RPMI 1640 with 5% FBS and penicillin/ streptomycin for 48 h in stationary vertical flasks at a cell fluorescence and then were incubated with PE-conjugated streptavidin (1:400 dilution) in PBS/FBS for 30 min on ice in density of 3ϫ10 7 cells/ml. Supernatants from these cells are hereafter referred to as TsF. The harvested supernatant of the dark. Then the PEC were washed twice and fixed in 0.2 ml of 1% paraformaldehyde in PBS. An aliquot of 10 4 cells of the cultured suppressive cells, that contained TNP-haptenspecific TsF, was used for suppression of CS-effector cell each specimen was analyzed in a FACStar Plus cytometer (Becton Dickinson, Mountain View, CA). responses in the in vitro IFN-γ production assay. IFN-γ production served as an in vitro assay of CS-effector cell function. This assay appeared suitable for measuring inhibitory TsF activity in vitro that was consistent with previous in vivo studies, demonstrating TsF suppression of ear swelling Statistics responses produced by adoptive transfer of CS effector cells Student's t-test was used for evaluation of the significance of (9-13). experimental differences and P Ͻ 0.05 was taken as level of statistical significance.
Recombinant sTCR protect CS-effector cells from the suppressive effect of TsF
Our previous in vivo studies demonstrated that preincubation Results of CS-effector cells in vitro with recombinant sTCR, prior to Suppressive factor inhibits IFN-γ production in vitro by CSincubation with TsF, protected CS-effector cells from suppreseffector cells sion in an adoptive cell transfer of CS (11) (12) (13) . To assess the effect of sTCR on TsF suppression in vitro, we again incubated TsF was obtained from culture supernatants of spleen cells of mice tolerized with i.v. injection of a high dose of the water-CS-effector LNC that were being stimulated with specific hapten-conjugated APC, but now with various concentrations soluble hapten antigen TNBSA. This TsF down-regulates CS responses in vivo, with genetic restriction and antigen of recombinant D10 sTCR without or together with a fixed dose of TsF (1:1 or a 50% concentration) (Fig. 2) . The positive specificity (9) (10) (11) . However, the effect of the TsF has not been demonstrated clearly in vitro. To establish a system to study control level of IFN-γ produced by CS-effector LNC (Group A) was reduced significantly (~60%) by TsF (Group B versus inhibition of CS mechanisms by TsF in vitro, we first measured IFN-γ production by CS-effector cells as a positive response, A, P Ͻ 0.001). Importantly, addition of D10 sTCR produced an apparent dose-dependent reversal of down-regulation since this cytokine is known to be one of the most important in elicitation of CS (7, 8) . Concentrations of IFN-γ in 48 h (Groups C-E). Employing log 10 increasing doses of sTCR, i.e. 1, 10 and 100 ng/ml sTCR respectively, progressively culture supernatants of cells from contact sensitized mice were determined by specific sandwich ELISA. As shown in reversed TsF suppression of IFN-γ production to 90, 99.4 and 128% of positive controls (Groups C-E versus Group A). Note that as little as 1 ng/ml recombinant sTCR was active (Group C, P Ͻ 0.001). Further, a high dose of 100 ng/ml D10 sTCR The production of IFN-γ was both immunization and antigen specific, since no IFN-γ production was detected (i.e. was completely prevented the inhibitory effect of TsF on IFN-γ production by CS-effector T cells (Groups D and E). In fact, below the limits of the assay) from co-incubation of nonimmune LNC together with TNP-APC (Group A) or by incubasTCR enhanced IFN-γ production by CS-effector cells dosedependently, in the absence of TsF (Groups F-H). tion of TNP-immune LNC together with heterologous mismatched hapten (Oxazolone)-conjugated APC (Group C).
We concluded that recombinant sTCR acted to prevent TsF-mediated down-regulation of antigen-specific IFN-γ proImportantly, culture of TNP-immune CS-effector cells with TNPconjugated APC, in the presence of various concentrations of duction by CS-effector cells and that sTCR even in the absence of suppression was able to augment IFN-γ producTsF, resulted in inhibition of IFN-γ production in a dosedependent manner (Fig. 1, Groups D-G) . In contrast, mock tion, suggesting that sTCR might act positively on the CSeffector cell mixture independently of added TsF. In additional TsF culture supernatant (undiluted, 100%) from naive mouse spleen cells did not affect IFN-γ production by CS-effector studies, we also confirmed that another sTCR, that instead was derived from a cytotoxic T cell clone (2C), showed similar cells (data not shown). We concluded that antigen-specific separately with or without 10 ng/ml of recombinant sTCR for 1 h at 37°C. After extensive washing, separate populations of the sTCRprepulsed immune LNC and TNP-APC were co-cultured in the presence (Groups C-G) or absence (Groups A and B) of downregulatory 50% TsF (a 1:1 dilution of supernatant) for 48 h at 37°C ability to enhance IFN production by CS-effector cells in vitro,
and then were combined with the opposite population that had or as was mediated by D10 sTCR (data not shown).
had not been prepulsed with sTCR, and then were cultured together
Regarding antigen specificity and MHC restriction, the and then IFN-γ production was determined in supernatants by ELISA. The data represent the mean Ϯ SE of triplicate samples. * P Ͻ 0.05, D10 TCR is known to bind a specific conalbumin peptide ** P Ͻ 0.001.
complexed with MHC class II k , while 2C TCR recognizes its peptide bound to MHC class I L d . Thus, these two TCR are quite different in antigen-MHC specificity. However, in soluble form these two αβ TCR molecules restored T h 1 function of Hcomparable protective effect (Fig. 4 , Group F versus C), as when CS-effector cells and TNP-APC were cultured together 2 k (CBA) effector cells. These results suggested that sTCR acted to augment IFN-γ production in a non-antigen-specific with sTCR (Group D versus C). In contrast, CS-effector cells pulsed alone with sTCR before mixing did not reverse and non-MHC-restricted manner, and thus that the antigen-MHC combining region of sTCR probably was not involved. suppression (Group E versus C). We also conducted similar experiments in the absence of TsF. Preincubation of sTCR However, as shown in Fig. 3 , protective activity by D10 sTCR was observed in vitro only when CS-effector cells were with TNP-APC prior to incubating with TNP-immune T cells enhanced IFN-γ production without TsF (by only 10%) (Group cultured with specific hapten-conjugated APC. Thus, sTCR induced IFN-γ production by PCl-immunized LNC that were B), while CS-effector cells incubated alone without TsF did not produce augmented IFN-γ after combining with TNP-APC. cultured with TNP-APC, but did not augment IFN-γ production when these TNP-immune LNC were cultured with unmatched Thus, we concluded that APC were the locus of action of recombinant sTCR, to restore the production of IFN. APC that instead were conjugated with OX, the wrong hapten (Groups C and D versus G and H). Therefore, it appeared that Cell surface binding of sTCR onto peritoneal exudate macrothe mechanism by which sTCR increased IFN-γ production by phages CS-effector cells was independent of the variable region of the sTCR molecules encoding antigen-MHC specificity, but
The effect of sTCR on APC suggested that sTCR might bind to APC directly and that the APC might thus be stimulated did depend on the quite different antigen-MHC specificity of the interaction between the CS-effector T cells and the APC.
by bound sTCR to somehow facilitate IFN-γ production by the CS-effector cells, resulting in protection from suppression. To sTCR acts via an effect on the APC to overcome TsF downdemonstrate possible direct binding of sTCR molecules to regulation of CS-effector T cells APC, we employed flow cytometry. We incubated biotinconjugated sTCR with thioglycolate-induced peritoneal exudWe next sought to determine the target cell(s) of recombinant sTCR in this culture system. The responses were largely due ate macrophages, as an enriched (Ͼ95%) population of APC. When macrophages were incubated with 50 µg/ml, to two different interacting cell populations in the assay, i.e. CS-effector T cells and TNP-hapten-conjugated splenic APC. biotinylated D10 sTCR (Fig. 5a ) or 2C sTCR (Fig. 5b ) and subsequent staining with phycoerythrin (PE) or FITC-avidin Thus, we separately preincubated each population with D10 sTCR for 60 min at 37°C and then washed to remove unbound was performed, then direct binding of sTCR onto the cell surface was observed. Staining was not obtained in controls sTCR. These separately sTCR-pulsed subpopulations were then combined with the other unpulsed subpopulation and mixed with PE or FITC-avidin alone. In fact, when APC were incubated with as little as 1 ng/ml biotin-D10 sTCR, a dose then together were incubated with TsF. After 48 h, the concentrations of IFN-γ in the supernatants were measured. that caused protection from suppression (Fig. 2, Group C) , staining of APC with FITC-avidin, was clearly greater than Preincubation of TNP-APC alone with sTCR produced a in the absence of TsF (Fig. 6a, Group D 
versus C). Addition
Thioglycolate-stimulated peritoneal macrophages (95%) were of anti-IL-12 showed a slight decrease of IFN-γ production by incubated with or without, biotin-conjugated sTCR from D10 T cells (Fig. 4a) or 2C T cells (Fig. 4b) CS-effector cells. Further, incubation of CS-effector cells with IL-12 itself (10 ng/ml) strongly overcame suppression by TsF and this effect was completely neutralized by addition of antistaining with FITC-avidin alone (Fig. 5a) . In a concurrent IL-12 antibody (data not shown). Taken together, these results experiment, macrophages were incubated with biotin-conjugsuggested that sTCR bound directly to the APC surface to ated both D10 and 2C sTCR showed a similar ability as induce IFN-γ production. This IFN-γ probably was produced unbiotinylated sTCR to induce IFN-γ production and protection by the T h 1 CS effector T cells. Alternatively IFN-γ could have from suppression (data not shown). Thus binding to APC and come from the APC, as it has been shown recently that APC induction of IFN-γ by T cells were associated properties and stimulated by IL-12 and IL-18 will produce IFN-γ (28), but we biotin conjugation did not interfere with this biologic property found that APC required co-incubation with T cells (Fig. 4 ) of sTCR.
and also APC did not produce IFN-γ when stimulated by IL-12 alone in this system (data not shown).
Effect of recombinant sTCR is mediated by IL-12 produced by the APC Production of IL-12 by peritoneal exudate macrophages
The data presented above suggest that sTCR act on APC stimulated by sTCR through direct binding to the APC surface. However the The above results suggested that direct binding of sTCR to mechanism of eventual induced IFN-γ production by T cells, the cell surface may induce IL-12 production by APC. To leading to apparent overcoming of the TsF suppressive action, confirm this possibility, we directly examined IL-12 production was still unclear. IL-12 is a heterodimeric (p40/p35) cytokine by peritoneal exudate macrophages incubated with recombinproduced by monocyte/macrophages and B cells that stimuant sTCR. To determine potential elaboration of IL-12 protein, lates growth of T h 1 cells and induces IFN-γ synthesis, while macrophages were incubated at a cell density of 10 6 /ml with simultaneously inhibiting T h 2 cytokine production (26) (27) (28) .
various concentrations of D10 or 2C sTCR for 48 h at 37°C. Recent studies indicate that IL-12 plays an important role in
The concentration of IL-12 in harvested culture supernatants potentiating in vivo T h 1 cell-mediated immune responses, was determined by specific quantitative sandwich ELISA. We notably CS (29, 30) . Therefore, we investigated the possible used LPS and IFN-γ stimulation as positive controls, that are involvement of IL-12 in augmentation of IFN-γ production known to induce production of IL-12 in macrophages. Figure  associated with protection from suppression. We added neut-7 shows that similar to LPS and IFN-γ (Groups B and C), both ralizing sheep polyclonal antibody specific for mouse IL-12 D10 sTCR (Fig. 7a , Groups D-F) and also 2C sTCR (Fig. 7b , to the cultures and then determined IFN-γ production after Groups D-F) significantly induced IL-12 production from 48 h. Figure 6 shows that adding anti-IL-12 completely peritoneal exudate macrophages in a dose-dependent abrogated the production of IFN-γ that was enhanced by sTCR in the presence of TsF (Fig. 6b, Group H versus G) or manner.
the role of the responsible CS-effector T cells and the putative modulatory role of soluble molecules derived from regulatory T cells (9) (10) (11) (12) (13) . Using this CS model, we previously described an antigen-specific soluble regulatory molecule(s) released spontaneously from an established T cell hybridoma AF5 that blocked the down-regulatory effect of TsF on CS-effector cells and had antigenic determinants of αβ TCR, but not of γδ TCR (11). This suppression-preventing factor, that was derived from the AF5 T cell hybridoma cells, mediated its effect as released disulfide-linked heterodimeric molecules that were structurally, functionally and serologically analogous to αβ TCR (11) . Partial characterization of this αβ TCR-related CSprotecting factor was carried out (11), but insufficient amounts of material were available for purification to yield enough material for more definitive characterization. This led us to examine similar up-regulation of in vivo CS by more abundant recombinant sTCR that was derived from D10 and 2C T cell clones (23). Our recent findings showed that pretreatment with these recombinant sTCR, protected CSeffector cells from suppression by TsF, in a system employing adoptive cell transfer of CS in vivo (12, 13) . However, the mechanism of protection was unclear. In the current study we attempted to devise an in vitro system to analyze the mechanisms by which sTCR protected CS-effector T cells from suppression. We employed two different kinds of soluble recombinant αβ TCR that were derived from either D10, a CD4 ϩ T h 2 clone, or from 2C, a CD8 ϩ cytotoxic T cell clone. We showed that both recombinant D10 sTCR [MHC class II (H-2 k )-restricted and specific for conalbumin peptide] and recombinant 2C sTCR [restricted in specifity to MHC class I other means. However, our prior study involved putative sTCR that had similar up regulatory function and were released from a T cell hybridoma spontaneously (11) .
Our findings suggested that sTCR protection from suppresDiscussion sion was neither antigen specific not MHC restricted and at the level of the sTCR, and thus confirmed prior in vivo findings We have demonstrated an in vitro functional effect of sTCR. Recombinant sTCR overcame down-regulatory effects of TsF that the same T h 2 H-2 k -and cytotoxic T lymphocyte H-2 dderived sTCR similarly protected H-2 k CBA CS effector T cells on IFN-γ production by immune CS-effector T cells that were responding to specific hapten-conjugated APC. Further, the in vivo, from similar suppression (13) . Taken together, along with the fact that sTCR were found to stimulate IL-12 producapparent reversal of down-regulation was probably due to induction of IL-12 secretion that was derived from the APC, tion from macrophages of different MHC and in the absence of any antigen, we concluded that the protective effect of following binding and direct stimulation by the sTCR. Thus, sTCR stimulation of APC led to IL-12 that protected T h 1 cells these recombinant sTCR was neither antigen nor MHC specific or restricted. Since antigen-peptide-MHC specificity of TCR from suppression.
Classically, in vivo cell-mediated immune responses, such is due to recognition via the variable regions of conventional transmembrane TCR, these results suggest that protection of as the PCl CS system in CBA mice, are mediated by CD4 ϩ αβTCR ϩ T h 1 effector T cells that characteristically produce CS by recombinant sTCR may have been mediated via the sTCR constant region. IFN-γ. In addition, recent studies have demonstrated that some CS and delayed-type hypersensitivity responses are
We demonstrated the presence of binding sites for sTCR on mouse peritoneal exudate macrophages by using immunomediated by CD8 ϩ T cells in which haptens are presented via MHC-class I molecules on APC, but resulting responses fluorescence and this correlated with protective function. We postulated that sTCR may bind to specific putative binding still depend largely on final IFN-γ secretion (29, 30) .
Adoptive cell transfer of CS with sensitized effector cells sites on the surface of APC, although the nature of possible receptors on macrophages for sTCR molecules is at present specific for chemically reactive haptens, such as PCl (TNPCl), is a well established in vivo model system for studying unclear. Two different sTCR bound to APC, represented by peritoneal exudate macrophages, in an antigen-and MHCaugment T h 1 responses or perhaps lead to release of other cytokines. independent manner, since no antigen was present, and H-2 k , as well as H-2 d -derived sTCR, bound to H-2 k macrophages
To date, there is only limited evidence for a naturally occurring soluble forms of TCR, as we have employed TCR equally.
In addition to this apparent reversal of suppression, it was in the recombinant form in the current in vitro studies. However, several studies favor the possible existence of sTCR in vivo. clear that sTCR led to IL-12 that stimulated CS-effector T cells in the absence of suppression. This finding suggested the Firstly, a variety of several cell surface membrane molecules related to TCR, such as MHC class I heavy chain (41), CD4 possibility that in some instances IL-12 overcame suppression due to its direct and strong positive action, rather than via (42) and CD8 (43) , are known to be enzymatically cleaved from the cell surface after activation, and then are released actual reversal. IL-12 is an important positive-acting cytokine that plays a crucial role in the regulation of cell-mediated to circulate in the serum in soluble form, as is true of many other cell surface receptors (44). Recently it was suggested immune responses, such as protective immunity in virus infections (31) or in parasite infestations like experimental that some of these soluble molecules in serum may be possible modulators of immune responses. For example, the Leishmaniasis (32,33). Accordingly, IL-12 mediates induction of protective T h 1 immune responses and, importantly, IL-12 serum level of HLA class I molecules increased during transplantation (45) and viral infections (46) , and decreased also promotes T h 1 responses by suppressing development of counteracting T h 2 cells and cytokines (28, 29) .
with immunosuppressive therapy (45) . Secondly, several laboratories have described the occurrence of soluble molecAccumulating evidence also has demonstrated the importance of IL-12 as a positive mediator in CS. For example, ules expressing TCRα determinants, as well as soluble molecules possibly related to αβ TCR, which in contrast to our CS ear swelling responses were decreased significantly in animals injected in vivo with anti-IL-12 during sensitization findings mediate immunosuppression (16) (17) (18) (19) (20) (21) . Thirdly, in contrast, we have described spontaneously released putative (30) , suggesting an important role of IL-12 in the induction of sensitized CS-effector T cells. Regarding tolerance to CS, the sTCR (11) , and in addition recombinant and unambiguous sTCR (12, 13) , that act positively in CS. Taken together, these detailed mechanisms are not fully understood by which highdose i.v. injection of hapten antigen induces an antigenresults favor the existence of sTCR in vivo. Also, it was reported recently that a specific and very sensitive ELISPOT specific tolerance. However, we observed recently that IL-12 reversed this type of CS tolerance, even when established, assay could detect sTCR released at the single-cell level. By using this assay, it was claimed that sTCR were released by suggesting that IL-12 can modulate elicited CS responses by acting positively on already developed CS-effector T cells T lymphoma cells, but not by B lymphoma, hepatoma or dead cells (47) . Further studies using this new assay for T cells and this effect was independent of IFN-γ (34). Also, others have noted that IL-12 prevents induction of UV-induced and also employing a sensitive ELISA that we reported to quantitate low levels of sTCR (24) may in the future provide hapten-specific tolerence (35) and can reverse established tolerance of CS effector cells induced by high-dose i.v. hapten useful information to clarify the possible role of sTCR in vivo. In summary, we have shown that recombinant sTCR bind (35) . Taken together, these studies demonstrate that systemic treatment with IL-12 can critically up-regulate CS. Of course, to APC and induce IL-12 production, which in turn protects T h 1 CS-effector cells from suppression, allowing IFN-γ producit is possible that other secondary cytokines may also play a role in IL-12-mediated effects on CS, such as protection from tion. It is possible that following some activation in vivo that αβ sTCR are released locally from T cells and then bind to suppression.
A new finding of this study was that sTCR could stimulate local APC to subsequently stimulate IL-12 production. This positive loop might then act to strengthen T h 1 immune IL-12 production from peritoneal exudate macrophages. This suggested that sTCR stimulation of increased in vitro producresponses in vivo, by maintaining or augmenting secretion of effector cytokines, such as IFN-γ. tion of IFN-γ by T h 1 CS-effector cells was dependent on IL-12 derived from APC, that were stimulated by sTCR, following binding to the APC surface, implying that this may involve a Acknowledgements receptor connected to positive signaling pathways in macrophages and other APC. Importantly, it was shown in another production. Besides exudate macrophages, perhaps other macrophage-related subpopulations, such as Langerhans cells (37) and dendritic cells (38) , or even B cells (39) 
